Enzo Biochem, Inc. (LON:0IHV)

Market Cap	21.34M
Revenue (ttm)	23.55M
Net Income (ttm)	-17.74M
Shares Out	n/a
EPS (ttm)	-0.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Nov 15, 2024

Volume	1,000
Average Volume	1,119
Open	0.540
Previous Close	n/a
Day's Range	0.540 - 0.550
52-Week Range	0.556 - 1.140
Beta	0.96
RSI	24.26
Earnings Date	Mar 18, 2025

About Enzo Biochem

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, ge...

• Industry: Laboratory Analytical Instruments
• Founded: 1976
• Employees: 136
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IHV

Financial Performance

Financial numbers in USD